Omalizumab for severe atopic dermatitis in 4- to 19-year-olds: the ADAPT RCT
Article in Efficacy and Mechanism Evaluation (May 2022)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Research progress in the effects of atopic dermatitis on progression of allergic reactions in children
Article in Chinese Journal of Primary Medicine and Pharmacy (April 2022)
What are the highest yielding search strategy terms for systematic reviews in atopic dermatitis? A systematic review
Article in Archives of Dermatological Research (November 2020)